LivaNova (LIVN) Accounts Payables (2015 - 2026)
LivaNova (LIVN) reported Accounts Payables of $99.1 million for Q1 2026, up 13.13% on a YoY basis from $87.6 million in Q1 2025, and up 2.05% sequentially from $97.2 million in Q4 2025.
LivaNova (LIVN) Accounts Payables (2015 - 2026) Analysis & Trends
LivaNova (LIVN) has 12 years of Accounts Payables data on file, last reported at $99.1 million in Q1 2026.
- For the quarter ending Q1 2026, Accounts Payables rose 13.13% year-over-year to $99.1 million; the trailing twelve-month figure through Mar 2026 stood at $99.1 million (up 13.13% YoY), and the FY2025 full-year result was $97.2 million, up 39.34% from the prior year.
- Accounts Payables improved to $99.1 million in Q1 2026, from $97.2 million in the prior quarter.
- In the past five years, Accounts Payables ranged from a high of $99.1 million in Q1 2026 to a low of $62.8 million in Q3 2023.
- A 5-year average of $79.6 million and a median of $77.9 million in 2024 frame the typical range for Accounts Payables.
- Across the five-year window, Accounts Payables retreated 13.75% in 2024 and soared 39.34% in 2025, its largest moves.
- Tracing LIVN's Accounts Payables over 5 years: stood at $74.3 million in 2022, then increased by 8.79% to $80.8 million in 2023, then fell by 13.75% to $69.7 million in 2024, then jumped by 39.34% to $97.2 million in 2025, then increased by 2.05% to $99.1 million in 2026.
- Business Quant data shows LIVN's Accounts Payables at $99.1 million in Q1 2026, $97.2 million in Q4 2025, and $88.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 4.68 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 1.59 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 2.64 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.14 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 181.10 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 2.33 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 3.41 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 1.18 Bn |
| 10 | LivaNova | 4.30 Bn | 3.76 Bn | 243.75 Mn | 99.15 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 99.15 Mn |
| Dec 31, 2025 | 97.16 Mn |
| Sep 30, 2025 | 88.16 Mn |
| Jun 30, 2025 | 86.93 Mn |
| Mar 31, 2025 | 87.64 Mn |
| Dec 31, 2024 | 69.73 Mn |
| Sep 30, 2024 | 77.89 Mn |
| Jun 30, 2024 | 81.32 Mn |
| Mar 31, 2024 | 75.94 Mn |
| Dec 31, 2023 | 80.85 Mn |
| Sep 30, 2023 | 62.78 Mn |
| Jun 30, 2023 | 78.21 Mn |
| Mar 31, 2023 | 75.73 Mn |
| Dec 31, 2022 | 74.31 Mn |
| Sep 30, 2022 | 69.62 Mn |
| Jun 30, 2022 | 74.35 Mn |
| Mar 31, 2022 | 73.92 Mn |
| Dec 31, 2021 | 68.00 Mn |
| Sep 30, 2021 | 60.25 Mn |
| Jun 30, 2021 | 61.33 Mn |